Vor bio successfully demonstrates multiplex editing of hematopoietic stem cells for next-generation aml treatment presented at eha

Multiplex deletion of myeloid antigens cd33 and cll-1 in human hematopoietic stem cells demonstrates potential of next-generation hsc transplants for treatment of acute myeloid leukemia

VOR Ratings Summary

VOR Quant Ranking